Cargando…
Using a genetic/clinical risk score to stop smoking (GeTSS): randomised controlled trial
BACKGROUND: As genetic tests become cheaper, the possibility of their widespread availability must be considered. This study involves a risk score for lung cancer in smokers that is roughly 50% genetic (50% clinical criteria). The risk score has been shown to be effective as a smoking cessation moti...
Autores principales: | Nichols, John A. A., Grob, Paul, Kite, Wendy, Williams, Peter, de Lusignan, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653992/ https://www.ncbi.nlm.nih.gov/pubmed/29061161 http://dx.doi.org/10.1186/s13104-017-2831-2 |
Ejemplares similares
-
Genetic test to stop smoking (GeTSS) trial protocol: randomised controlled trial of a genetic test (Respiragene) and Auckland formula to assess lung cancer risk
por: Nichols, John AA, et al.
Publicado: (2014) -
Combining TSS-MPRA and sensitive TSS profile dissimilarity scoring to study the sequence determinants of transcription initiation
por: Guzman, Carlos, et al.
Publicado: (2023) -
Flexible analysis of TSS mapping data and detection of TSS shifts with TSRexploreR
por: Policastro, Robert A, et al.
Publicado: (2021) -
High Sensitivity TSS Prediction: Estimates of Locations Where TSS Cannot Occur
por: Schaefer, Ulf, et al.
Publicado: (2010) -
Structure of the type VI secretion system TssK–TssF–TssG baseplate subcomplex revealed by cryo-electron microscopy
por: Park, Young-Jun, et al.
Publicado: (2018)